AstraZeneca (NASDAQ:AZN) reported quarterly earnings of $2.63 per share which beat the analyst consensus estimate of $2.48 by 6.05 percent. This is a 141.28 percent increase over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $15.384 billion which missed the analyst consensus estimate of $15.459 billion by 0.48 percent. This is a 6.41 percent increase over sales of $14.457 billion the same period last year.